Retrospective analysis of the emergence of antibiotic-resistant Salmonella enterica infections in a level IV hospital from Lima, Peru
- Joaquim Ruiz(corresponding author),
- Wilfredo Flores-Paredes,
- Nestor Luque,
- Roger Albornoz,
- Nayade Rojas,
- Manuel Espinoza
- ,
- Hospital Guillermo Almenara Irigoyen,
- Universidad Peruana Union,
- Ministerio de Salud, Lima,
- Instituto Nacional de Salud, Lima
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 68-73 (6 pages)Journal (Volume, Issue Number)
Tropical Doctor (Volume 52, Issue 1)Publication milestones
- Accepted/In press - 2021
- Published - 01/2022
Publication status
ISSN
0049-4755Publication IDs
- Scopus: 85121736292
Abstract
This study retrospectively analysed the emergence of multidrug-resistant Salmonella enterica in a level IV hospital in Lima, Peru. A total of 64 S. enterica from January 2009 to June 2010 (Period 1, 24 isolates) and January 2012 to December 2014 (Period 2, 40 isolates) were included. Some 25 were from non-hospitalized and 39 from hospitalized patients. Antimicrobial susceptibility to 15 antimicrobial agents was established by automated methods. Most of the isolates were from blood (46.9%), urine (21.9%) and faeces (14.1%). There was a reduction in blood isolates in Period 2, while all the faecal isolates were from this period. In Period 1, only 3/24 (12.5%) isolates showed antibiotic resistance, whereas 25/39 isolates (64.1%) from Period 2 were antibiotic-resistant, with multidrug-resistant and extensively drug-resistant rates of 17.9% and 20.5%, respectively. Multidrug-resistant/extensively drug-resistant Salmonella isolates were introduced in the hospital in 2013, with Salmonella recovered from faeces from non-hospitalized patients suggested an increase in community-acquired multidrug-resistant/extensively drug-resistant Salmonella infections.
Funding Details
Access to documents
Publication metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
